Zdrowie i gospodarka · 27/07/2018

FDA Releases Draft Guidance on Reducing Babesiosis Risk in Blood Transfusions

The Food and Drug Administration (FDA) has released a draft guidance document outlining recommendations to reduce the risk of babesiosis being transmitted through blood transfusions. The guidance focuses on donor screening, testing, deferral, and product management for blood establishments.